Skip to content
VLOCMarket desk
Switch to dark mode

News

Explore market and company news with sources and timestamps.

Current data
Each article’s publication time
Next data
New data per source
Expected availability
No confirmed schedule
Region and source
Topic

Topics are assigned from article titles and may differ from the publisher’s categories.

News for 317450 Clear filter

News coverage is partial. Showing available news.

  1. 정신질환 치료 선택지 넓히는 제약업계···신약 도입부터 DTx까지 (new window)

    Other newswww.monews.co.krKO
    Related stocks명인제약부광약품
    Read supplied summary — 정신질환 치료 선택지 넓히는 제약업계···신약 도입부터 DTx까지

    부광약품 은 라투다(성분명 루라시돈) MDD 적응증 확대를 추진한다. 알보젠코리아는 해외 ADHD 치료제의 국내 도입을 위한 가교임상을 진행 중이다. 명인제약도 파트너사가 개발 중인 치료저항성 조현병 신약의 글로벌...

    Summary supplied by the source. Open the original for the full article.

Each item includes its publisher, timestamp and original link. Article times differ from market data dates.